Dartmouth College:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Dartmouth College - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9269
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Dartmouth College (Dartmouth) is an educational institution that offers education and research services. The institute provides various programs in the field of art history, languages and literatures, english and creative writing, film and media studies, sociology, psychological and brain sciences, physics and astronomy, environmental studies, biological science, earth science, engineering science, computer science, and others. It operates various centers such as Center for Social Impact, Institute for Health Policy and Clinical Practice, Center for Global Business and Government, Center for Advancement of Learning, Institute for Computational Science, Center for Public Policy, and others. The institute operates through its research centers and institutes located in New Hampshire, the US. Dartmouth is headquartered in Hanover, New Hampshire, the US.

Dartmouth College – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Dartmouth College, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Dartmouth College, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Dartmouth College, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Dartmouth College, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Dartmouth College, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Dartmouth College, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Qrons Enters into Option Agreement with Trustees of Dartmouth College 10
Licensing Agreements 11
OnCyte Amends Licensing Agreement with Dartmouth College 11
ChromaDex Extends Licensing Agreement with Dartmouth College for Nicotinamide Riboside 13
ChromaDex Enters Into Licensing Agreement With Dartmouth College For Nicotinamide Riboside Technology 14
Dartmouth College – Key Competitors 15
Dartmouth College – Key Employees 16
Dartmouth College – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Government and Public Interest 18
Sep 19, 2018: NIH announces awards for behavioral research on OUD prevention and treatment 18
Aug 14, 2018: SCU awarded NIH grants for studies advancing our understanding of spine pain treatment 19
Sep 25, 2017: Streamlined process opens drug development to a new class of steroids 20
Other Significant Developments 21
Mar 19, 2018: Dartmouth United Way Campaign Raises Over $294,000 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Dartmouth College, Pharmaceuticals & Healthcare, Key Facts 2
Dartmouth College, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Dartmouth College, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Dartmouth College, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Dartmouth College, Deals By Therapy Area, 2012 to YTD 2018 8
Dartmouth College, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Qrons Enters into Option Agreement with Trustees of Dartmouth College 10
OnCyte Amends Licensing Agreement with Dartmouth College 11
ChromaDex Extends Licensing Agreement with Dartmouth College for Nicotinamide Riboside 13
ChromaDex Enters Into Licensing Agreement With Dartmouth College For Nicotinamide Riboside Technology 14
Dartmouth College, Key Competitors 15
Dartmouth College, Key Employees 16
Dartmouth College, Other Locations 17
Dartmouth College, Subsidiaries 17

List of Figures
Dartmouth College, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Dartmouth College, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Dartmouth College, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Dartmouth College, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Dartmouth College, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Dartmouth College, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Dartmouth College, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Dartmouth College, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Dartmouth College:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Goodyear Tire & Rubber Company:企業の戦略・SWOT・財務分析
    The Goodyear Tire & Rubber Company - Strategy, SWOT and Corporate Finance Report Summary The Goodyear Tire & Rubber Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Isetan Mitsukoshi Holdings Ltd (3099):企業の財務・戦略的SWOT分析
    Isetan Mitsukoshi Holdings Ltd (3099) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Sangetsu Corporation (8130):企業の財務・戦略的SWOT分析
    Sangetsu Corporation (8130) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • GENTEX Corp:企業の戦略的SWOT分析
    GENTEX Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Esperion Therapeutics Inc (ESPR)-製薬・医療分野:企業M&A・提携分析
    Summary Esperion Therapeutics Inc (Esperion) is a pharmaceutical company that develops and commercializes oral therapies to treat patients with elevated low-density lipoprotein cholesterol (LDL-C). The company’s lead product candidate, Bempedoic acid, an ATP-citrate lyase inhibitor which is in Phase …
  • Paratek Pharmaceuticals Inc (PRTK):企業の財務・戦略的SWOT分析
    Paratek Pharmaceuticals Inc (PRTK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Navigator Holdings Ltd (NVGS):石油・ガス:M&Aディール及び事業提携情報
    Summary Navigator Holdings Ltd (Navigator) is an oil and gas company that offers seaborne transportation of liquefied gases. The company transports ammonia, ethane, ethylene, ambient LPG, petrochemicals and LPG products. It provides fleet management, ship management, gas transportation and consultan …
  • University of Glasgow-製薬・医療分野:企業M&A・提携分析
    Summary University of Glasgow (UOG) is an educational and research institute that offers undergraduate, post graduate, and online programs. The institute operates through its departments for law, medicine, veterinary medicine and dentistry. It offers courses across various disciplines that include a …
  • Australian Leaders Fund Limited
    Australian Leaders Fund Limited - Strategy, SWOT and Corporate Finance Report Summary Australian Leaders Fund Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • BliNK Biomedical SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary BliNK Biomedical SAS (BliNK Biomedical) is a drug development company that discovers and develops antibody-based therapeutics for life threatening diseases such as cancer. The company’s lead pipeline program is a monoclonal antibody that targets novel immune-oncology and immune-checkpoint ta …
  • Calpine Corporation:戦略・SWOT・企業財務分析
    Calpine Corporation - Strategy, SWOT and Corporate Finance Report Summary Calpine Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • China Petroleum & Chemical Corporation (600028)-エネルギー分野:企業M&A・提携分析
    Summary China Petroleum & Chemical Corporation (Sinopec), a subsidiary of China Petrochemical Corporation, is a vertically integrated energy and chemical company. It is involved in the oil and gas exploration and production, extraction, pipeline transmission and marketing; oil refining; and producti …
  • University of California Los Angeles-製薬・医療分野:企業M&A・提携分析
    Summary University of California Los Angeles (UCLA) a subsidiary of University of California is an educational service provider that offers undergraduate education, graduate, professional education and continuing education. The university’s services include support services, campus services, graduat …
  • Coutts & Co:企業の戦略・SWOT・財務分析
    Coutts & Co - Strategy, SWOT and Corporate Finance Report Summary Coutts & Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Fred Hutchinson Cancer Research Center-医療機器分野:企業M&A・提携分析
    Summary Fred Hutchinson Cancer Research Center (Fred Hutchinson), a subsidiary of National Comprehensive Cancer Network, is a nonprofit organization which conducts research on the prevention, diagnose and treatment of cancer, HIV/AIDS and other life threatening diseases. It conducts research on vari …
  • Faroe Petroleum Plc (FPM):石油・ガス:M&Aディール及び事業提携情報
    Summary Faroe Petroleum Plc (Faroe Petroleum) is an oil and gas company that concentrates on exploration, appraisal, development and production opportunities. The company has its exploration and development assets in the UK. Its operations portfolio consists of exploration, appraisal, development an …
  • transcosmos Inc:企業の戦略・SWOT・財務分析
    transcosmos Inc - Strategy, SWOT and Corporate Finance Report Summary transcosmos Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Distilleries Company of Sri Lanka PLC:企業の戦略・SWOT・財務情報
    Distilleries Company of Sri Lanka PLC - Strategy, SWOT and Corporate Finance Report Summary Distilleries Company of Sri Lanka PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • MedinCell SA:製薬・医療:M&Aディール及び事業提携情報
    Summary MedinCell SA (MedinCell) is a developer of therapeutic solutions for the healthcare market. The company develops and commercializes BEPO, a technology based on custom proprietary copolymers and a biocompatible solvent for long acting injectables. Its BEPO provides a controlled release of the …
  • GE Energy Power Conversion Group:企業の戦略的SWOT分析
    GE Energy Power Conversion Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆